The life sciences industry is at a turning point in corporate communications. Treating Investor Relations (IR) and External Communications (EC) as separate functions no longer meets the demands of today’s complex stakeholder landscape. Investors expect consistent narratives aligned with public positioning, media outlets seek compelling yet scientifically accurate stories, and regulators require compliance across all channels.
This white paper introduces a practical framework for integrating IR and EC into a unified approach. You’ll learn why integration is critical, the challenges companies face, and how to operationalize effective strategies that ensure message consistency, regulatory compliance, and stakeholder engagement.
